ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 28 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,000 | -33.3% | 6,869 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | -25.0% | 6,869 | 0.0% | 0.00% | – |
| Q2 2016 | $12,000 | +9.1% | 6,869 | +19.4% | 0.00% | – |
| Q1 2016 | $11,000 | -42.1% | 5,755 | 0.0% | 0.00% | – |
| Q4 2015 | $19,000 | +111.1% | 5,755 | +9.3% | 0.00% | – |
| Q3 2015 | $9,000 | -30.8% | 5,267 | +5.4% | 0.00% | – |
| Q2 2015 | $13,000 | -92.9% | 4,998 | -93.2% | 0.00% | – |
| Q1 2015 | $182,000 | -49.2% | 73,717 | +21.3% | 0.00% | – |
| Q4 2014 | $358,000 | -11.8% | 60,770 | +0.2% | 0.00% | -100.0% |
| Q3 2014 | $406,000 | +1.5% | 60,626 | +9.4% | 0.00% | 0.0% |
| Q2 2014 | $400,000 | – | 55,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 8,147,650 | $2,864,000 | 0.84% |
| Consonance Capital Management LP | 37,000,000 | $13,006,000 | 0.78% |
| CVI Holdings, LLC | 2,850,477 | $1,002,000 | 0.37% |
| SABBY MANAGEMENT, LLC | 972,285 | $342,000 | 0.07% |
| J. Goldman & Co LP | 2,150,385 | $756,000 | 0.05% |
| Virtu Financial LLC | 668,600 | $235,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 130,000 | $46,000 | 0.01% |
| Summit X, LLC | 68,200 | $24,000 | 0.01% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 107,200 | $38,000 | 0.01% |
| Laidlaw Wealth Management LLC | 28,000 | $10,000 | 0.01% |